Application and comparison of PET/CT, contrast enhanced CT and MRI in the clinical manage-ment of pancreatic cancer
10.3760/cma.j.issn.2095-2848.2017.10.014
- VernacularTitle:PET/CT在胰腺癌诊治中的应用及与增强CT和MRI的比较
- Author:
Huanhuan CHONG
1
;
Xiaoli LAN
Author Information
1. 华中科技大学同济医学院附属协和医院核医学科、湖北省分子影像重点实验室
- Keywords:
Pancreatic neoplasms;
Positron-emission tomography;
Tomography,X-ray computed;
Magnetic resonance imaging;
Trends
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2017;37(10):654-659
- CountryChina
- Language:Chinese
-
Abstract:
Recently, either in the field of preoperative differential diagnosis and staging, or in the diagnosis of postoperative recurrence and distant metastasis, the application of PET/CT in pancreatic cancer attracts more and more attention. Combining the precise anatomical information of CT with the functional metabolic information of PET, 18 F-FDG PET/CT can not only accurately locate the T staging, but also de-tect regional or distant metastasis, which make the early diagnosis and staging of pancreatic cancer easier. This review summarizes the recent progress of PET/CT imaging in the clinical application of pancreatic cancer by comparison of the contrast enhanced CT and MRI, trying to analyze different imaging modalities in clinical management of pancreatic cancer.
